Texas Department of State Health Services 
Funding Information Center Toll free: 1-888-963-7111 ext. 7684 Austin phone: (512) 776-7684 Fax: (512) 776-7683
The Texas Department of State Health Services Funding Alert is published weekly. If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://webds.dshs.state.tx.us/fic/subscribe.htm. Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.
Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.
Funding News and Grant Tips
Aetna Foundation, CDC to conduct 'Safety Net Hospital' Study
The Aetna Foundation is supporting efforts by the National Public Health & Hospital Institute (NPHHI), the research affiliate of the National Association of Public Hospitals & Health Systems (NAPH), to conduct a study on ways to help so-called safety-net hospitals provide care for those with no or limited health insurance. The research seeks to help reduce the number of Americans who use safety-net hospitals and emergency rooms as their primary care providers.
The Centers for Disease Control & Prevention will award one grant of $800,000 to conduct research to design and test the feasibility of a surveillance system for congenital and inherited conditions that have low prevalence but high health and economic impact in the U.S. population. Initial design of this surveillance system will focus on three conditions exemplifying different types of disorders: e.g., spina bifida is an example of a neurological condition affecting mobility; muscular dystrophy is an example of a neuromuscular condition; and fragile X syndrome is an example of a condition affecting cognition and behavior. The project will develop a prototype surveillance system that can serve as a model for other low prevalence/high impact conditions.
The system should: help providers describe the epidemiology and features of secondary health conditions associated with these disorders; monitor the progress of public health interventions; develop screening strategies for the detection of new cases; and address potential differences or disparities in the impact of these conditions on the population.
Applications are due March 2. See http://tinyurl.com/6pkg6ey for more information.
From Community Health Funding Report, 1/6/12
Early CPRIT Grant Recipient Receives FDA Approval for System
The Cancer Prevention and Research Institute of Texas (CPRIT) congratulates Apollo Endosurgery, one of the Institute’s first company investment grant recipients, for receiving approval from the U.S. Food and Drug Administration to begin marketing its SuMO endoscopic tissue access and resection system. The SuMO system is designed to allow the scarless surgical removal of certain precancerous gastrointestinal lesions during endoscopy procedures that include treatment for colorectal cancer.
From CPRIT e-mail, 1/10/12
Public Funding Opportunities
Clinical Trials in Organ Transplantation in Children (U01): RFA-AI-12-005
SOURCE: National Institute of Allergy and Infectious Diseases (NIAID)
APPLICATION DEADLINE: Letter of Intent: 3/18/12. Application: 4/18/12.
$ AVAILABLE: NIAID intends to commit $4.3 million in total costs to fund three to four awards in FY2013.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: This funding opportunity will support a consortium of investigators to conduct clinical trials (Phase I,II, or III) and/or observational clinical studies, accompanied by mechanistic studies, in pediatric solid organ transplant recipients (subjects must be less than 21 years of age at the time of enrollment) who have undergone heart, lung, liver, small intestine, and/or kidney transplantation. Research supported under this announcement will focus on reducing long-term graft dysfunction and/or loss and immune-mediated morbidity and mortality unique to pediatric transplant recipients.
CFDA: 93.855, 93.856
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-005.html
From NIH Web site, accessed 1/11/12
Subject(s) children's health, medical research
Minor Use Minor Species Development of Drugs; Research Project Grant (R01): RFA-FD-12-003
SOURCE: Food and Drug Administration (FDA), Office of Minor Use and Minor Species (MUMS) Animal Drug Development
APPLICATION DEADLINE: 2/17/12, 7/20/12, 12/7/12, 7/26/13, 12/6/13, 7/18/14, 12/5/14.
$ AVAILABLE: Of the estimated $750,000 available in each fiscal year, FDA anticipates funding approximately eight to 10 awards in each FY, subject to availability of funds.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions/organizations that propose to develop, or support the development of, new animal drugs intended for minor use in major species or intended for use in minor species. Only new animal drug products that have been designated in accordance with the provisions of section 573 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR Part 516 are eligible for grants. FDA is authorized to provide grants for designated new animal drugs to assist in defraying the costs of qualified safety and effectiveness testing.
CFDA: 93.103
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-003.html
From NIH Web site, accessed 1/11/12
Subject(s) medical research, veterinary medicine
Molecular Characterization of Salivary Gland Tumors (R01): RFA-DE-12-011
SOURCE: National Institute of Dental and Craniofacial Research (NIDCR)
APPLICATION DEADLINE: Letter of Intent: 2/19/12. Application: 3/19/12.
$ AVAILABLE: NIDCR intends to support three to four R01 applications solicited through this Funding Opportunity Announcement (FOA). A companion FOA, RFA-DE-12-012, will support an additional three to four R21 exploratory/developmental grant applications. NIDCR intends to commit up to $2 million in total costs in FY2012 to support meritorious projects solicited through these two FOAs.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) solicits Research Project Grant (R01) applications to enhance basic and translational research on salivary gland tumors by supporting studies in a) the application of systematic, comprehensive, and data-rich “omics” approaches to define the molecular signatures of salivary gland tumors; and b) the development of relevant mouse models to study the onset and progression of tumor pathogenesis and preclinical testing of potential therapeutics.
CFDA: 93.121
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-12-011.html
From NIH Web site, accessed 1/11/12
Subject(s) medical research, cancer research
Molecular Characterization of Salivary Gland Tumors (R21): RFA-DE-12-012
SOURCE: National Institute of Dental and Craniofacial Research (NIDCR)
APPLICATION DEADLINE: Letter of Intent: 2/19/12. Application: 3/19/12.
$ AVAILABLE: NIDCR intends to support three to four R21 exploratory/developmental grant applications solicited through this FOA. A companion FOA, RFA-DE-12-011, will support an additional three to four R01 applications. NIDCR intends to commit up to $2 million in total costs in FY2012 to support meritorious projects solicited through these two FOAs.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) issued by the National Institute of Dental and Craniofacial Research (NIDCR) solicits R21 Exploratory/Developmental Research Grant (R21) applications to enhance basic and translational research on salivary gland tumors by supporting studies in a) the application of systematic, comprehensive, and data-rich “omics” approaches to define the molecular signatures of salivary gland tumors; and b) the development of relevant mouse models to study the onset and progression of tumor pathogenesis and preclinical testing of potential therapeutics.
CFDA: 93.121
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-12-012.html
From NIH Web site, accessed 1/11/12
Subject(s) medical research, cancer research
Multidisciplinary Clinical Research Centers (P60): RFA-AR-13-001
SOURCE: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICATION DEADLINE: Letter of Intent: 4/18/12. Application: 5/18/12.
$ AVAILABLE: NIAMS intends to fund up to three awards, corresponding to a total of $3.6 million, for fiscal year 2013. Future year amounts will depend on annual appropriations.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health, invites new and renewal applications for Multidisciplinary Clinical Research Centers (MCRCs) in arthritis, musculoskeletal disorders, and/or skin diseases. Each MCRC will be organized around a methodology core. In addition to this core, each center must include a minimum of two highly meritorious clinical projects focused on diseases or conditions within the NIAMS mission.
CFDA: 93.846
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-13-001.html
From NIH Web site, accessed 1/11/12
Subject(s) medical research
Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54): RFA-HD-13-005
SOURCE: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
APPLICATION DEADLINE: Letter of Intent: 5/27/12. Application: 6/27/12.
$ AVAILABLE: The NICHD intends to commit approximately $3.5 million in total costs in FY 2013 to fund up to two new and/or renewal applications.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this funding opportunity announcement (FOA) is to announce the re-competition of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR). The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provides funding for a limited number of research centers in the reproductive sciences. These centers provide an arena for multidisciplinary interactions between basic and clinical scientists interested in arch programs in the area of reproductive health and infertility. The centers also serve as a national resource for the training and career development of new scientists electing to pursue careers conducting translational research in high priority areas of reproduction and infertility. Finally, center investigators are expected to participate in important community outreach and education efforts to increase awareness and convey the importance and implications of their research activities to the general public.
CFDA: 93.865
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-13-005.html
From NIH Web site, accessed 1/11/12
Subject(s) women's health, medical research, health professions training, community health
Private Funding Opportunities
Wellstone Fellowship for Social Justice
SOURCE: Families USA
APPLICATION DEADLINE: 1/27/12.
$ AVAILABLE: The fellowship runs from August 2012 through July 2013, and the fellow will receive a compensatory package that includes an annual salary of approximately $38,000 and excellent healthcare benefits.
ELIGIBILITY: Candidates must demonstrate an interest in healthcare policy as a tool for reducing racial and ethnic health disparities and in using organizing and advocacy skills to achieve social change. Applicants also should demonstrate a commitment to contributing to social justice advocacy following their year of hands-on experience as a fellow.
PURPOSE: Families USA, a national nonprofit, nonpartisan organization dedicated to the achievement of high-quality, affordable healthcare for all Americans, is accepting applications for the Wellstone Fellowship for Social Justice and the Villers Fellowship for Health Care Justice.
Each year, one person is chosen for each of these fellowships to work in Families USA's Washington, D.C. office for a year.
The Wellstone Fellowship for Social Justice is designed to foster the advancement of social justice through participation in healthcare advocacy work that focuses on the unique challenges facing many communities of color. The fellowship is designed to increase the number of low-income, American Indian and Alaska Native, Asian American, Black/African American, Latino, and Native Hawaiian and Pacific Islander social justice leaders.
CONTACT: Families USA, 1201 New York Avenue NW, Suite 1100, Washington, DC 20005, (202) 628-3030, e-mail: info@familiesusa.org. For more information see http://www.familiesusa.org/fellowships/wellstone-fellowship.html
From The Foundation center's Philanthropy News Digest Web site accessed 1/12/12
Subject(s) health professions training, minority health, health policy research
Events
Ask, Screen, Intervene
SPONSOR: Denver STD/HIV Prevention Training Center, Texas Department of State Health Services (DSHS)
WHEN: February 23, 11:30 am to 4:30 pm.
WHERE: AIDS Services of Austin, 7215 Cameron Rd. Suite A, (Austin, TX).
DESCRIPTION: This course aims to assist HIV care providers in learning new techniques to incorporate important intervention methods during the medical visit (even in the constrained care setting), in order to help their patients reduce risk behaviors. It is targeted to medical care providers of HIV positive patients (e.g., MDs, NPs, RNs, PAs); however, persons who deliver prevention messages (e.g., case managers, social workers, health educators) may also benefit from the information and techniques delivered throughout the course. Topics covered are: brief screening for HIV transmission risk behaviors; identifying and treating other STDs; communicating prevention messages; discussing sexual and drug-use behaviors; referring selected patients for additional prevention interventions and services; facilitating partner notification, counseling, and testing of sex and needle-sharing partners of infected persons.
COST: Free. A box lunch will be provided.
CONTACT: Please see http://denverptc.org/class_information.html?id=578 for contact information.
From DSHS HIV-STD Program HIV-STD Insider e-mail, 1/12/12
Become a Strategic Non-Profit Leader
SPONSOR: Center for Community-Based and Nonprofit Organizations at Austin Community College (CCBNO ACC)
WHEN: January 25, 1 to 5 pm.
WHERE: Austin Community College - Highland Business Center, 5930 Middle Fiskville Road, Room 411, (Austin, TX).
DESCRIPTION: We all get lost in busy-ness and want more control of our Non-Profit Organization (NPO) and our lives. The common mantra of the NPO leaders we speak to is “If I can only put in more hours, I’ll achieve my goals”… Unfortunately, more hours don’t always result in more productivity.
This hands-on, interactive workshop allows participants to face this challenge head-on and gives them the insight and skills needed to become a strategic non-profit leader.
The learning objectives for this workshop are:
* For you to slow down, reflect, and invest some focused time working "on" your NPO and life, not "in" your NPO.
* Take a "NPO Reality Checkup."
* Challenge your current mindset, assumptions & modes of operation.
* Discover critical traps most NPOs fall into.
* Identify overlooked marketing opportunities.
* Sharpen your vision & goals.
* Start to create a 90-day strategic plan.
* Meet and collaborate with other non-profit leaders.
* Experience a small sample of our proven & guaranteed Strategic Mindset ® coaching & accountability process.
Presented by professional business coaches, Dean Bogues, Scott Merritt and Dag Nybo, this workshop will help you become more focused, strategic and successful.
COST: $70 TANO members / $90 non-members.
CONTACT: Neelam Noorani, (512) 223-7111, e-mail: nnoorani@austincc.edu.
From CCBNO ACC e-mail, 1/11/12
Effective Grant Writing
SPONSOR: Center for Community-Based and Nonprofit Organizations at Austin Community College (CCBNO ACC)
WHEN: February 7, 9 am to 4 pm.
WHERE: Austin Community College - Highland Business Center, 5930 Middle Fiskville Road, Room 103.2, (Austin, TX).
DESCRIPTION: This course is a complete one-day “nuts and bolts” guide to grant proposal development and management of critical proposal development processes. Participants will develop a detailed outline of a full grant proposal and develop logical and compelling narrative and spreadsheets in the challenging sections of needs assessments, objectives, evaluation and budget. Participants will also develop strategies for researching, cultivating, communicating, and building partnerships with foundation, corporation, and government funders.
Additionally, the workshop will cover “important yet rarely-discussed” topics such as writing and editing styles, expectations and measurement of a successful grant writing program, the relationship of grants to overall organizational fundraising, the role of management and volunteer leadership in grant-development initiatives, and organizational team-building to support grant proposal development. Comprehensive handouts and online resources are provided.
This workshop has been highly rated as effective for both the beginner and advanced grant-writer, because of the unique perspectives provided by the presenter.
COST: $75 TANO members / $99 non-members.
CONTACT: Neelam Noorani, (512) 223-7111, e-mail: nnoorani@austincc.edu.
From CCBNO ACC e-mail, 1/11/12
Return to Alert